442 related articles for article (PubMed ID: 19459970)
21. The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2.
Seele J; Hillermann LM; Beineke A; Seitz M; von Pawel-Rammingen U; Valentin-Weigand P; Baums CG
Vaccine; 2015 May; 33(19):2207-2212. PubMed ID: 25825330
[TBL] [Abstract][Full Text] [Related]
22. Induction of protective immune response against Streptococcus suis serotype 2 infection by the surface antigen HP0245.
Li W; Hu X; Liu L; Chen H; Zhou R
FEMS Microbiol Lett; 2011 Mar; 316(2):115-22. PubMed ID: 21204934
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaning.
Baums CG; Brüggemann C; Kock C; Beineke A; Waldmann KH; Valentin-Weigand P
Clin Vaccine Immunol; 2010 Oct; 17(10):1589-97. PubMed ID: 20739502
[TBL] [Abstract][Full Text] [Related]
24. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.
Baums CG; Kock C; Beineke A; Bennecke K; Goethe R; Schröder C; Waldmann KH; Valentin-Weigand P
Clin Vaccine Immunol; 2009 Feb; 16(2):200-8. PubMed ID: 19109449
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and cross-protective efficacy of double-mutant Streptococcus suis ΔSspepO/ΔSspspC serotypes 2 and 7.
Hu J; Xu J; Liu F; Tan C; Yuan F; Chen H; Bei W
Vaccine; 2019 Apr; 37(16):2194-2199. PubMed ID: 30902483
[TBL] [Abstract][Full Text] [Related]
26. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity study of a Streptococcus suis autogenous vaccine in preparturient sows and evaluation of passive maternal immunity in piglets.
Corsaut L; Martelet L; Goyette-Desjardins G; Beauchamp G; Denicourt M; Gottschalk M; Segura M
BMC Vet Res; 2021 Feb; 17(1):72. PubMed ID: 33546699
[TBL] [Abstract][Full Text] [Related]
28. Prevalent distribution and conservation of Streptococcus suis Lmb protein and its protective capacity against the Chinese highly virulent strain infection.
Zhang YM; Shao ZQ; Wang J; Wang L; Li X; Wang C; Tang J; Pan X
Microbiol Res; 2014; 169(5-6):395-401. PubMed ID: 24120016
[TBL] [Abstract][Full Text] [Related]
29. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.
Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W
Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838
[TBL] [Abstract][Full Text] [Related]
30. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2.
Zhou Y; Wang Y; Deng L; Zheng C; Yuan F; Chen H; Bei W; Li J
Vaccine; 2015 May; 33(19):2254-2260. PubMed ID: 25820064
[TBL] [Abstract][Full Text] [Related]
32. Immunoproteomic assay of membrane-associated proteins of Streptococcus suis type 2 China vaccine strain HA9801.
Zhang W; Lu CP
Zoonoses Public Health; 2007; 54(6-7):253-9. PubMed ID: 17803514
[TBL] [Abstract][Full Text] [Related]
33. A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection.
Mandanici F; Gómez-Gascón L; Garibaldi M; Olaya-Abril A; Luque I; Tarradas C; Mancuso G; Papasergi S; Bárcena JA; Teti G; Beninati C; Rodríguez-Ortega MJ
J Proteomics; 2010 Nov; 73(12):2365-9. PubMed ID: 20656083
[TBL] [Abstract][Full Text] [Related]
34. Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection.
Garibaldi M; Rodríguez-Ortega MJ; Mandanici F; Cardaci A; Midiri A; Papasergi S; Gambadoro O; Cavallari V; Teti G; Beninati C
Vaccine; 2010 Apr; 28(20):3609-16. PubMed ID: 20079873
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with the Mycoplasma suis recombinant adhesion protein MSG1 elicits a strong immune response but fails to induce protection in pigs.
Hoelzle K; Doser S; Ritzmann M; Heinritzi K; Palzer A; Elicker S; Kramer M; Felder KM; Hoelzle LE
Vaccine; 2009 Aug; 27(39):5376-82. PubMed ID: 19596408
[TBL] [Abstract][Full Text] [Related]
36. Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.
Hu J; You W; Wang B; Hu X; Tan C; Liu J; Chen H; Bei W
Microbiol Res; 2015 Jan; 170():87-94. PubMed ID: 25220429
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
[TBL] [Abstract][Full Text] [Related]
38. Identification of immunogenic cell wall-associated proteins of Streptococcus suis serotype 2.
Zhang A; Xie C; Chen H; Jin M
Proteomics; 2008 Sep; 8(17):3506-15. PubMed ID: 18686301
[TBL] [Abstract][Full Text] [Related]
39. Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets.
Jeffery A; Gilbert M; Corsaut L; Gaudreau A; Obradovic MR; Cloutier S; Frenette MC; Surprenant C; Lacouture S; Arnal JL; Gottschalk M; Segura M
Vet Res; 2024 May; 55(1):57. PubMed ID: 38715138
[TBL] [Abstract][Full Text] [Related]
40. Immunisation of pigs with killed cultures of Streptococcus suis type 2.
Holt ME; Enright MR; Alexander TJ
Res Vet Sci; 1990 Jan; 48(1):23-7. PubMed ID: 2300710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
